Evidence map›Paper›PMID 29514565›Full record

Trial reportPhlebology2019

Venous stent patency may be affected by collateral vein lumen size.

Timme Maj van Vuuren, Suat Doganci, Irwin M Toonder, Rick De Graaf, Cees Ha Wittens

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Phlebology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Timme Maj van Vuuren1 Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
Suat Doganci3 Department of Cardiovascular Surgery, University of Health Sciences, Ankara, Turkey.
Irwin M Toonder1 Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
Rick De Graaf5 Department of Radiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Cees Ha Wittens1 Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
RWTH Aachen University · DEMaastricht University · NLMaastricht University Medical Centre · NLSağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDeep venous thrombosis causes blood flow deviation. It is hypothesized that with stent placement, developed collateral veins become redundant. This article evaluates the relation between the surface area of the collaterals and stent patency.

methodsThe azygos and hemiazygos veins were identified and the largest surface area was measured at thoracic level. Patency rates of stented tracts were evaluated and related to collateral vein lumen size.

resultsThe vena cava occlusion and the azygos and hemiazygos vein surface area measurements were positive and statistically significant related (OR 1.01, 95% CI 1.003-1.019, p = 0.004) respectively (and OR 1.007, 95% CI 1.001-1.013, p = 0.004). An azygos surface area measurement of 23 (p<0.001) and hemiazygos surface area measurement of 40 (p = 0.008) was shown as cut-off point related to higher occlusion rates.

conclusionsThe surface area of major venous collateral pathways seems to be related to stent occlusion in deep venous interventions.

Indexed as

Azygos VeinStentsTomography, X-Ray ComputedVena Cava, InferiorVenous ThrombosisAdolescentAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedDeep vein thrombosisendovascular treatmentpost-thrombotic syndrome

Identifiers

PMID29514565
PMCPMC6348454
OpenAlexW2790327220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.